Abstract:The modern healthcare system faces an unrelenting threat from microorganisms, as evidenced by global outbreaks of new viral diseases, emerging antimicrobial resistance, and the rising incidence of healthcare-associated infections (HAIs). An effective response to these threats requires rapid and accurate diagnostic tests that can identify causative pathogens at the point of care (POC). Such tests could eliminate diagnostic uncertainties, facilitating patient triaging, minimizing the empiric use of antimicrobial drugs, and enabling targeted treatments. Current standard methods, however, often fail to meet the needs of rapid diagnosis in POC settings. Culture-based assays entail long processing times and require specialized laboratory infrastructure; nucleic acid (NA) tests are often limited to centralized hospitals due to assay complexity and high costs. Here we discuss two new POC tests developed in our groups to enable the rapid diagnosis of infection. The first is nanoPCR that takes advantages of core-shell magnetoplasmonic nanoparticles (MPNs): (i) Au shell significantly accelerates thermocycling via volumetric, plasmonic light-to-heat conversion and (ii) a magnetic core enables sensitive in situ fluorescent detection via magnetic clearing. By adopting a Ferris wheel module, the system expedites multisamples in parallel with a minimal setup. When applied to COVID-19 diagnosis, nanoPCR detected SARS-CoV-2 RNA down to 3.2 copy/μL within 17 min. In particular, nanoPCR diagnostics accurately identified COVID-19 cases in clinical samples (n = 150), validating its clinical applicability. The second is a polarization anisotropy diagnostic (PAD) system that exploits the principle of fluorescence polarization (FP) as a detection modality. Fluorescent probes were designed to alter their molecular weight upon recognizing target NAs. This event modulates the probes' tumbling rate (Brownian motion), which leads to changes in FP. The approach is robust against environmental noise and benefits from the ratiometric nature of the signal readout. We applied PAD to detect clinically relevant HAI bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus). The PAD assay demonstrated detection sensitivity down to the single bacterium level and determined both drug resistance and virulence status. In summary, these new tests have the potential to become powerful tools for rapid diagnosis in the infectious disease space. They do not require highly skilled personnel or labor-intensive analyses, and the assays are quick and cost-effective. These attributes will make nanoPCR and PAD well-aligned with a POC workflow to aid physicians to initiate prompt and informed patient treatment.

Microfluidic-based Colorimetric Nucleic Acid Detection of Pathogens

Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens

Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches

Advances in Nucleic Acid Amplification-Based Microfluidic Devices for Clinical Microbial Detection

Recent advances in nucleic acid analysis and detection with microfluidic and nanofluidics

Recent advancements in nucleic acid detection with microfluidic chip for molecular diagnostics

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

Development of Integrated Systems for On-Site Infection Detection

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Microfluidics for Rapid Detection of Live Pathogens

[Methods of isothermal nucleic acid amplification-based microfluidic chips for pathogen microorganism detection]

Microfluidic System for Microbial Pathogen Detection

Recent advances in microfluidic devices for foodborne pathogens detection

Smartphone-assisted point-of-care testing of nucleic acids based on hybridization chain reaction, magnetic beads, and gold nanorods etching

Gold nanoparticle-based colorimetric platform technology as rapid and efficient bacterial pathogens detection method from various sources

Microfluidics-based strategies for molecular diagnostics of infectious diseases

On‐Chip Optical Detection of Viruses: A Review

Point-of-care diagnostics for infectious diseases: From methods to devices

Centrifugal microfluidic system for colorimetric sample-to-answer detection of viral pathogens

Dual-mode visual detection strategies of viable pathogens for point-of-care testing